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Abstract
Background: Pancreatic fibrosis is a prominent histopathological characteristic of chronic pancreatitis and plausibly
a dynamic process of transition to the development of pancreatic ductal adenocarcinoma. Conversely, the
activation of pancreatic stellate cells (PSCs) has been recently suggested as the key initiating step in pancreatic
fibrosis. As natural polyphenols had been largely applied in complementary therapies in the past decade, in this
study, we aimed to investigate which groups of phenolic compounds exert promising inhibitory actions on
fibrogenesis as there are few effective strategies for the treatment of pancreatic fibrosis to date.
Methods: We examined the anti-fibrotic effects of a variety of herbal constituents using a cellular platform, the
LTC-14 cells, which retained essential characteristics and morphologies of primary PSCs, by means of various
biochemical assays including cell viability test, real-time polymerase chain reaction and Western blotting analysis.
Results: Among a number of commonly used herbal constituents, we found that the application of rhein, emodin,
curcumin and resveratrol significantly suppressed the mRNA and protein levels of several fibrotic mediators namely
alpha-smooth muscle actin, type I collagen and fibronectin in LTC-14 cells against transforming growth factor-beta
stimulation. Though the values of cytotoxicity varied, the mechanism of the anti-fibrotic action of these four
phenolic compounds was principally associated with a decrease in the activation of the nuclear factor-kappaB
signaling pathway.
Conclusions: Our findings suggest that the mentioned phenolic compounds may serve as anti-fibrotic agents in
PSC-relating disorders and pathologies, particularly pancreatic fibrosis.
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Background
Over the recent years, an increasing body of evidence has
suggested that pancreatic stellate cells (PSCs) play a critical
role in the development of fibrogenesis in the pancreas,
which plausibly a dynamic process of transition to pancre-
atic ductal adenocarcinoma (PDAC). In normal condition,
PSCs are quiescently localized at the periacinar region of
the exocrine pancreas while exhibiting numerous retinoid-
containing droplets and synthesizing relatively low amounts
of extracellular matrix (ECM) proteins [1]. When activated,
for instance, upon injury or inflammatory events, PSCs
transform into the myofibrolast-like phenotype, which can
be identified with the presence of alpha-smooth muscle
actin (α-SMA or Acta2), a large amount of ECM proteins
and various kinds of cytokines and/or growth factors [2]. It
is believed that the PSCs are activated for the purpose of
tissue repairing and regeneration as a consequence of tissue
damage or inflammatory reactions. Hence, perpetuated ac-
tivation of PSCs had been observed in chronic inflamma-
tory condition of the pancreas [3] as well as pancreatic
fibrosis [4]. Moreover, the co-localization of α-SMA and
major ECM proteins, namely type I collagen-α1 (COL I-α1)
and fibronectin 1 (FN1) at the active fibrotic areas indicated
the activation of PSCs and appeared to be positively corre-
lated to the degree of fibrogenesis [5]. The overwhelmed
production and deposition of ECM in an organ, not merely
the pancreas, causes scarring of the parenchyma, which
was replaced by connective tissues [6]. Tissue scarring is in-
deed an irreversible process that provokes permanent mor-
phological damages and impairment of the organ; thus,
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resulting in anatomical anomalies, dysfunction of organs
and cancer progression [7, 8]. Taken together, the activation
of PSCs is crucial to the development of pancreatic fibrosis,
pancreatitis and PDAC.
Herbal constituents, especially phenolic compounds,
have been received increasing interest in the past de-
cades largely owing to their reported beneficial effects
on longevity and disease prevention. As a result, for
combating fibrotic conditions, the use of natural remed-
ies has an obvious appeal among a variety of comple-
mentary and alternative approaches. In fact, phenols are
a group of natural constituents produced as secondary
metabolites by higher plants for defending against biotic
and abiotic challenges [9]. The chief chemical feature of
phenols is their possession of one or more hydroxyl
groups on the core aromatic rings. In general, phenolic
compounds are abundant in our dietary food, fruits and
beverages, for example, red grapes, berries, peanuts, red
wine and tea [10], and have been documented with nu-
merous health benefits to humans, such as the anti-
oxidant [11], anti-aging [12], anti-inflammatory [13] and
anti-tumor [14] biological properties; thus, they are also
known as micronutrients. In the current study, we aimed
to examine which classes of these micronutrients pro-
vide promising anti-fibrotic effects on PSCs as strategies
for effective treatment of pancreatic fibrosis are urgently
needed. From our previous studies [4, 15], we noticed
that the activation of PSCs was essentially important to
the development of pancreatic fibrogenesis. Therefore,
the immortalized LTC-14 cell line, which retained the
essential characteristics and morphological features of
primary PSCs [16] was employed in our in vitro study as
a cellular screening platform.
By means of various biochemical assays, we found
that amongst the about forty herbal constituents that
we screened, four phenolic compounds, rhein, emodin,
curcumin and resveratrol notably suppressed PSC-
enhancing gene expressions and substances. Import-
antly, their inhibitory modulations on fibrotic media-
tors were associated with a suppression of the nuclear
factor-kappaB (NF-κB) signaling. Our findings suggest
that the mentioned phenolic compounds may serve as
potential remedies for treatment or alleviation of pan-
creatic fibrosis and/or PSC-relating pathologies.
Methods
Reagents
Rhein (C15H8O6, molecular weight: 284.225), emodin
(C15H10O5, molecular weight: 270.24) and curcumin
(C21H20O6, molecular weight: 368.38) were purchased
from Nanjing Zelang Medical Technology Company
Limited, China. Resveratrol (C14H12O3, molecular weight:
228.24) was provided by Dr. Hongjie Zhang of the School
of Chinese Medicine, Hong Kong Baptist University, Hong
Kong SAR, China. All compounds were proved with a pur-
ity of ≥ 98 %, and their chemical structures were provided
in Fig. 1. The herbal compounds were reconstituted in di-
methyl sulfoxide at a concentration of 1000 μM, and stored
at -20 °C until use. Recombinant transforming growth
factor-beta (TGF-β) was purchased from Sigma-Aldrich,
USA.
Cell line and culture condition
Rat pancreatic stellate cell line LTC-14 [16] was kindly
provided by Prof. Robert Jaster from University Hospital
of Rostock, Germany, and was routinely maintained in
Iscove’s modified Dulbecco’s medium (IMDM, GIBCO)
supplemented with 10 % fetal bovine serum (FBS, GIBCO)
and 1 % penicillin-streptomycin (GIBCO) in a 5 % CO2,
95 % air humidified atmosphere at 37 °C.
Cell viability assays
The cytotoxicities of herbal constituents in LTC-14 cells
were assessed in terms of mitochondrial metabolism by
utilizing the 3-(4,5-cimethylthiazol-2-yl)-2,5-diphenyl
tetrazolium bromide (MTT, Sigma-Aldrich) cell viability
assay. LTC-14 cells were seeded in 96-well plates at a
density of 8 × 103 cells/ml and incubated with serial dilu-
tions of phenolic compounds including rhein, emodin,
curcumin and resveratrol (1 to 1000 μM) for 24 or 48 h
(h). Subsequently, cells were treated with MTT reagent
at 37 °C for 3 h and then with isopropanol-hydrochloric
acid at room temperature for 0.5 h. Spectrophotometric
absorbance of samples were measured at 570 nm using a
microplate reader (Bio-rad). In addition, LTC-14 cells
treated with phenolic compounds were also subjected to
crystal violet staining for a further evaluation of cell pro-
liferation. In brief, cells were treated with rhein (50 μM),
emodin (10 μM), curcumin (50 μM) and resveratrol
(50 μM), fixed with ice-cold methanol for 15 min, rinsed
with phosphate buffered saline (PBS) twice, and stained
with 0.5 % crystal violet solution for 10 min. Stained
cells were thoroughly washed with PBS and allowed air
dry. Images were taken under a light microscope (Leica)
with a magnification of 100 × .
Real-time quantitative polymerase chain reaction (qPCR)
LTC-14 cells were seeded at a density of 5 × 104 cells/ml in
24-well plates, cultured in IMDM supplemented with 1 %
FBS and pre-incubated with recombinant TGF-β at 10 ng/
ml for 24 h. Subsequently, cells are treated with rhein, cur-
cumin or resveratrol at 20 μM or emodin at 4 μM for an-
other 24-h period. At the time of harvest, total RNA was
extracted from LTC-14 cells using TRIzol reagent (Invitro-
gen) according to the manufacturer’s instruction. Two μg
of total RNA of each sample was transcribed into cDNA
using PrimeScript RT master mix (Takara) in a total vol-
ume of 20 μl. cDNA templates were then amplified with
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rat-specific primers for Acta2, Col I-α1, Fn1 and Gapdh in
the ABI ViiA 7 real-time PCR system (Applied Biosystems)
using 2X SYBR Green PCR Master Mix (Applied Biosys-
tems). Expression of gene of interest of each sample was
normalized to the endogenous control Gapdh, and pre-
sented as 2-ΔΔCt using the comparative Ct method. Primer
sequences for qPCR analysis are listed in Table 1.
Western blot analysis
For the detection of NF-κB, the nuclear protein was ex-
tracted from LTC-14 cells utilizing specialized nuclear ex-
traction buffers and differential centrifugation speed. Total
protein was extracted using RIPA lysis buffer containing
protease inhibitor. Cell lysates at 10 μg were loaded and
separated by SDS-polyacrylamide gel electrophoresis. After
wet electroblotting, proteins were transferred onto PVDF
membranes (Bio-rad) and blocked with 5 % non-fat milk.
Electroblots were probed with primary antibodies, i.e. anti-
α-SMA (Abcam), anti-TUBULIN (Cell Signaling), anti-NF-
κB p65 (Cell Signaling) or anti-Histone H3 (Cell signaling)
overnight at 4 °C, incubated with corresponsive horseradish
peroxidase-conjugated anti-rabbit, anti-goat or anti-mouse
secondary antibodies, and visualized by utilization of an
ECL kit (GE Healthcare).
Statistical analysis
The statistical differences were determined using one-
way analysis of variance (ANOVA) followed by Tukey’s
post hoc test. All values are expressed as means ± stand-
ard derivation (S.D.). P value of < 0.05 is accepted as sta-
tistically significant.
Results
Cytotoxicity of phenolic compounds in LTC-14 cells
The cytotoxicity of the testing herbal constituents in
LTC-14 cells was firstly assessed in terms of mito-
chondrial metabolism. LTC-14 cells were treated with
rhein, emodin, resveratrol or curcumin at various con-
centrations (1 to 1000 μM) for 24 and 48 h. Our MTT
results demonstrated that the mitochondrial metabolic
rates of LTC-14 cells were decreased in response to
the treatment of the phenolic compounds in a dose-
dependent fashion (Fig. 2). Emodin exhibited a high
cytotoxicity. The LD50 of emodin at both 24- and 48-h
time-points were roughly 20 μM. For rhein, curcumin
and resveratrol, their LD50 in LTC-14 cells at the 24-
and 48-h time-points were all higher than 120 μM. Be-
sides the MTT assay, LTC-14 cells were also subjected
to crystal violet staining for a further evaluation of
their proliferation rates at concentrations lower than
their LD50 values. LTC-14 cells were incubated with
rhein (50 μM), emodin (10 μM), curcumin (50 μM)
and resveratrol (50 μM) for 24 h prior to the crystal
violet staining. Nevertheless, notable inhibitory effects
Fig. 1 The chemical structures of phenolic compounds rhein, emodin, curcumin and resveratrol. The chemical structures of rhein, C15H8O6,
molecular weight: 284.225; emodin, C15H10O5, molecular weight: 270.24; curcumin, C21H20O6, molecular weight: 368.38, and resveratrol, C14H12O3,
molecular weight: 228.24
Table 1 List of primer sequences designed for the qPCR
approach
Primer Sequence
Acta2_forward 5′-AGA GTG GAG AAG CCC AGC CAG TC-3′
Acta2_reverse 5′-GGG CCA CGC GAA GCT CGT TAT AG-3′
Col I-α1_forward 5′-CAG GCG AAC AAG GTG ACA GAG GC-3′
Col I-α1_reverse 5′-GGT TGC AGC CTT GGT TAG GGT CG-3′
Fn1_forward 5′-ATC ACC TGG ACC CCC GCT CC-3′
Fn1_reverse 5′-CGG TTC CCT GCT GCC CGT TT-3′
Gapdh_forward 5′-AGA GAG AGG CCC TCA GTT GCC TG-3′
Gapdh_reverse 5′-AGG CCC CTC CTG TTG TTA TGG GG-3′
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of these four compounds on LTC-14 cell proliferation
were observed (Fig. 3). Therefore, rhein, curcumin and
resveratrol were applied at concentrations lower than
50 μM whereas emodin was applied at less than
10 μM in subsequent experiments to avoid cytotoxic
effects.
Phenolic compounds suppressed fibrotic mediators in
LTC-14 cells
TGF-β was used as a fibrogenic inducer in our experi-
ment though an endogenous amount of TGF-β was
present in the culturing condition. According to our
qPCR result, when exogenous TGF-β (10 ng/ml) was
Fig. 2 The cytotoxicity of phenolic compounds in LTC-14 cells. LTC-14 cells were treated with phenolic compounds for 24 and 48 h and subjected to MTT
assay for the evaluation of their effects on cell viability in terms of mitochondrial metabolism. LTC-14 cells were treated with rhein (a), emodin (b), curcumin
(c) or resveratrol (d) at 1, 10, 100 and 1000 μM
Fig. 3 Effects of phenolic compounds on rate of proliferation in LTC-14 cells. LTC-14 cells were treated with phenolic compounds for 24 h and
subjected to crystal violet staining for the evaluation of their effects on cell proliferation. LTC-14 cells were treated with rhein at 50 μM, emodin at
10 μM, curcumin at 50 μM or resveratrol at 50 μM
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added, the mRNA levels of fibrotic filament Acta2 and
ECM mediators Col I-α1 and Fn1 in LTC-14 cells were
up-regulated by roughly 3 to 6 folds. Upon the treatment
of rhein, curcumin or resveratrol at 20 μM or emodin at
4 μM, expression levels of Acta2 (Fig. 4a), Col I-α1
(Fig. 4b) and Fn1 (Fig. 4c) were significantly suppressed.
Consistent with the qPCR results, the protein levels of
α-SMA in LTC-14 cells were as well remarkably lowered
by rhein, emodin, curcumin and resveratrol (Fig. 5a).
With reference to our MTT results, the LD50 of rhein,
curcumin and resveratrol were higher than 120 μM. To
this end, the suppressive properties of these three phen-
olic compounds on fibrotic mediators at 20 μM in our
experiments were not due to their cytotoxic effects,
though emodin exhibited a relatively high cytotoxicity.
Phenolic compounds suppressed NF-κB signaling
With the aid of the nuclear loading reference Histone H3
on the Western blotting images, we observed that the
nuclear expression of NF-κB in the LTC-14 cells was sig-
nificantly elevated by the stimulation of TGF-β (10 ng/ml)
when compared to that of the unstimulated control, in
which the nuclear NF-κB level was relatively low. Upon the
treatment of rhein, curcumin or resveratrol at 20 μM or
emodin at 4 μM, the levels of NF-κB p65 were markedly
reduced in the nuclear subfraction (Fig. 5b).
Discussion
Over the past few decades, herbal supplements have been
increasingly utilizing in a wide spectrum of applications,
and phenolic compounds have been documented with a
number of health-promoting benefits [17, 18]. Among the
about forty herbal constituents that we screened, rhein, em-
odin, curcumin and resveratrol demonstrated the most
promising anti-fibrotic actions against TGF-β stimulation
in cultured PSCs. Indeed, these four compounds belong to
different classes of phenols.
Rhein and emodin are anthraquinone constituents of
rhubarb extracts that have been used as laxatives as
well as bird repellents for a long history. Recently, they
have been shown to exert inhibitory activities in several
inflammatory conditions including pancreatitis [4], liver
injury [19] and intervertebral disc degeneration [20].
They have also been repurposed as anti-microbial and
anti-cancer agents [21]. Though the application of rhein
and emodin on inhibiting activation of PSCs has yet
been intensively investigated, some of the anthraquione
analogs have been shown to exert protective effects
against hepatic fibrosis [19, 22]. In line with previous
findings, the results of current study indeed demon-
strated the promising anti-fibrotic effects of these two
anthraquinones; however, the cytotoxicity of emodin
cannot be disregarded.
Curcumin, a biphenolic active turmeric compound, also
known as the curcuminoid, of the ginger family, has been
used in Ayurvedic medicine for thousands of years as a de-
toxifying agent. Recently, curcumin has been reported with
potent anti-inflammatory and anti-cancer bioactivities in
Fig. 4 Suppressive effects of phenolic compounds on fibrotic
mediators. LTC-14 cells were treated with recombinant TGF-β at
10 ng/ml for 24 h prior to the incubation of rhein at 20 μM, emodin
at 4 μM, curcumin at 20 μM or resveratrol at 20 μM. Transcripts of
Acta2 (a), Col I-1α (b) and Fn1 (c) were amplified by means of qPCR.
Ct values of the amplified transcripts of the gene of interest were
normalized to the endogenous reference Gapdh and expressed as
fold changes over the non-TGF-β-treated control. * P < 0.05 when
comparing to the control whereas # p < 0.05 when comparing to
the TGF-β treatment
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various in vitro and in vivo models [23, 24]. Furthermore,
Zhai et al showed that curcumin significantly suppressed
the activation of hepatic stellate cells [25]. The results of
our present study were in agreement with the previous re-
ports that curcumin reduced fibrotic mediators in PSCs.
On the other hand, resveratrol is a member of the sti-
benoid family, and is indeed a renowned anti-oxidant. It
has been shown to be beneficial to a variety of medical
conditions and physiological processes, particularly via
its activation of Sirtuin 1 [26]. Nevertheless, studies on
its anti-fibrotic actions are rather limited.
In the current study, the anti-fibrotic actions of herbal
constituents were investigated with the aid of the rat PSC
line LTC-14, which was proved to retain essential charac-
teristics and morphological features of primary PSCs [16].
In this regard, this cell line is considered as a suitable and
relevant mammalian cellular model for the study of pancre-
atic fibrotic events. Importantly, the activation of PSCs is
essentially critical to the development of fibrogenesis in the
pancreas. Our results showed that rhein, emodin, curcumin
and resveratrol significantly inhibited the production of
major fibrogenic mediators including Acta2, Col I-α1 and
Fn1 in LTC-14 cells and the underlying mechanism was as-
sociated with the down-regulation of the NF-κB signaling
pathway.
Previous works of our research group reported that rhein
exhibited potent anti-fibrotic effect as it significantly ame-
liorated the severity of pancreatic fibrosis in the course of
chronic pancreatitis in vivo [4] and inhibited the production
of fibrogenic mediators in PSCs against TGF-β stimulation
in vitro [15]. Hence, the anti-fibrotic actions of phenolic
compounds were of our great interest as there are very few
strategies for effective treatment of pancreatic fibrosis avail-
able to date. In this study, we observed that emodin, a com-
mon anthraquinone with chemical structure vastly similar
to rhein, provided inhibitory effects comparable to rhein on
the expression of fibrotic mediators. However, we also no-
ticed that emodin was highly cytotoxic to the cultured PSCs
as the LD50 were determined to be roughly 20 μM at differ-
ent time points. It is plausible that some of its inhibitory
effects might be derived from its cytotoxicity. Findings of
others revealed that emodin at low concentrations pro-
moted growth inhibition in pulmonary adenocarcinoma
cells [27] and breast carcinoma cells [28]. Taken together,
we suggest emodin should be applied to PSCs at a concen-
tration no higher than 5 μM. The efficacy and physiological
range of emodin in vivo definitely warrant detailed investi-
gation. Without affected by cytotoxicities, curcumin and
resveratrol effectively attenuated the expression levels of
Acta2, Col I-α1 and Fn1 against TGF-β stimulation. In
addition to the TGF-β-induced fibrotic actions, Masamune
and colleagues demonstrated that curcumin also effectively
inhibited platelet-derived growth factor-induced PSC acti-
vation [29]. Moreover, in agreement with other previous
findings, the suppressive effects of curcumin and resvera-
trol, so as those of rhein and emodin, were associated with
the modulation of the NF-κB signaling pathway [24, 30].
The nuclear translocation of NF-κB dimmers indeed de-
noted the transactivation of its target genes encoding in-
flammatory and/or fibrotic mediators in response to tissue
injury. Not merely limited to pancreatic fibrogenesis, the
majority of pro-fibrotic mediators that initiate fibrosis-
related signaling cascades converge at the activation of NF-
κB, which is also considered as the central signal transducer
for apoptotic and inflammatory processes in various kinds
of mammalian cells [31, 32]. Upon the activation of NF-κB,
high levels of cytokines and chemotactic factors accompan-
ied with the overwhelmed ECM proteins secreted by PSCs
create a microenvironment that propagates desmoplastic
reaction, by which the initiation and development of PDAC
is promoted [15, 33]. As a result, the activation of the NF-
κB signaling pathway is crucial to pancreatic fibrogenesis as
well as PDAC.
A variety of herbal constituents have been demosnstrated
with significant health-promoting benefits; not many of
them have been clinically used as therapeutic remedies, but
Fig. 5 Effect of phenolic compounds on expression of α-SMA and NF-
κB. LTC-14 cells were treated with recombinant TGF-β (10 ng/ml) and
rhein at 20 μM, emodin at 4 μM, curcumin at 20 μM or resveratrol at
20 μM. Extracted nuclear and cytoplasmic proteins were subjected to
Western blotting analysis. Protein levels of α-SMA in the cytoplasmic
fraction were visualized on immunoblots probed with anti-α-SMA (a)
whereas levels of NF-κB in the nuclear fraction were probed
anti-NF-κB p65 (b) antibodies whereas TUBULIN and Histone H3
were served as loading references of the cytoplasmic and nuclear
fractions respectively
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they have been widely consumed as health supplements.
The underlying mechanisms of their beneficial effects are
undoubtedly the scientific grounds for their applications.
The testing phenolic compounds of this study have been
reported to be well absorbed by the human bowel; however,
their bioavailabilities remain questionable as they are often
rapidly metabolized by gut microbiota. The enhancement
of bioavailability, for instance, the preparation of co-crystals
as well as improved delivery systems undeniably deserve
further investigation.
Conclusions
Our screening results provided a hint in revealing the
potential anti-fibrotic agents including rhein, emodin,
curcumin and resveratrol as they effectively attenuated
PSC-enhancing gene expressions and substances. Im-
portantly, their suppressive effects were associated with
an inhibition of the NF-κB signaling. Our findings sug-
gest that these four phenolic compounds may serve as
anti-fibrotic agents for treatment or alleviation of pan-
creatic fibrosis and PSC-relating pathologies including
PDAC.
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